Assertio Holdings is back in focus after its fair value estimate was reset from US$37.44 to US$21.33, a cut of roughly 43% that reflects a more cautious stance on the stock. Analysts are weighing this ...

$ASRT insiders have traded $ASRT stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales. Here’s a ...

Insider selling in Assertio raises red flags and erodes trust in management's statements. The magnitude and frequency of insider sales cast doubt on the company's trajectory and prompt a cautious ...

Assertio (ASRT) closed the last trading session at $18.41, gaining 60.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street ...

Shares of Assertio Holdings, Inc. (ASRT) fell 1.5% after hours on Wednesday after the company said that it has entered into ...

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Assertio (ASRT) been one of those stocks this year? By taking a look at the ...

Detailed price information for Assertio Therapeutics Inc (ASRT-Q) from The Globe and Mail including charting and trades.

Assertio Therapeutics (ASRT) has shared an announcement. At a recent Annual Meeting, stockholders approved significant changes to the Company’s incentive plan and bylaws, including a 3.39 million ...

Shares of Assertio (ASRT) have gained 28.9% over the past four weeks to close the last trading session at $11.78, but there could still be a solid upside left in the stock if short-term price targets ...